Portfolio

Pfizer

Pfizer

Pfizer Data Integration

MetaCell supported Pfizer's investment in the creation of digital biomarkers and signatures of disease states that can be detected from digital devices to assist in the drug discovery R&D process.

No items found.
No items found.
No items found.

Pfizer is investing in the creation of digital biomarkers and signatures of disease states that can be detected from digital devices, to assist in the drug discovery R&D process. MetaCell is leveraging its expertise in data integration and working within the corporate environment to deliver real solutions for data science activities.

Testimonial person picture
Client's logo

About the CLIENT

Pharma

Date

July 2020

Learn more

Take a closer look
No items found.